Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Net Cash Flow (2010 - 2026)

Incyte's (INCY) quarterly Net Cash Flow came in at $521.3 million in Q2 2026, up 3465.1% YoY from $14.6 million in Q2 2025, and up 42.45% on a QoQ basis from $366.0 million in Q1 2026.

Analysis

Incyte (INCY) Net Cash Flow (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Net Cash Flow data on file, last reported at $521.3 million in Q2 2026.

  • Quarterly Net Cash Flow rose 3465.1% year-over-year to $521.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.0 billion (up 110.15% YoY) and the FY2025 annual result came in at $1.4 billion, up 192.36% from the prior year.
  • Net Cash Flow grew to $521.3 million in Q2 2026, from $366.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $643.6 million in Q4 2025 to a low of -$2.4 billion in Q2 2024.
  • A 5-year average of $107.2 million and a median of $254.1 million in 2022 frame the typical range for Net Cash Flow.
  • The widest YoY moves for Net Cash Flow: up 6016.68% in 2024, down 856.15% in 2024.
  • Tracing INCY's Net Cash Flow over 5 years: stood at $260.3 million in 2022, then plunged by 102.47% to -$6.4 million in 2023, then surged by 6016.68% to $380.1 million in 2024, then surged by 69.31% to $643.6 million in 2025, then declined by 19.0% to $521.3 million in 2026.
  • The last three Net Cash Flow figures came in at $521.3 million (Q2 2026), $366.0 million (Q1 2026), and $643.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 521.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 521.33 Mn
Mar 31, 2026 365.97 Mn
Dec 31, 2025 643.62 Mn
Sep 30, 2025 499.20 Mn
Jun 30, 2025 14.62 Mn
Mar 31, 2025 254.49 Mn
Dec 31, 2024 380.15 Mn
Sep 30, 2024 316.79 Mn
Jun 30, 2024 -2.36 Bn
Mar 31, 2024 133.29 Mn
Dec 31, 2023 -6.43 Mn
Sep 30, 2023 93.39 Mn
Jun 30, 2023 311.97 Mn
Mar 31, 2023 -130.15 Mn
Dec 31, 2022 260.27 Mn
Sep 30, 2022 253.67 Mn
Jun 30, 2022 177.58 Mn
Mar 31, 2022 199.09 Mn
Dec 31, 2021 58.31 Mn
Sep 30, 2021 203.00 Mn